The DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index, and 1 are not checked yet.
Allele-Specific Chromosome Removal after Cas9 Cleavage in Human Embryos
Open accessPublished version of a preprint
Abstract
Correction of disease-causing mutations in human embryos holds the potential to reduce the burden of inherited genetic disorders and improve fertility treatments for couples with disease-causing mutations in lieu of embryo selection. Here, we evaluate repair outcomes of a Cas9-induced double-strand break (DSB) introduced on the paternal chromosome at the EYS locus, which carries a frameshift mutation causing blindness. We show that the most common repair outcome is microhomology-mediated end joining, which occurs during the first cell cycle in the zygote, leading to embryos with non-mosaic restoration of the reading frame. Notably, about half of the breaks remain unrepaired, resulting in an undetectable paternal allele and, after mitosis, loss of one or both chromosomal arms. Correspondingly, Cas9 off-target cleavage results in chromosomal losses and hemizygous indels because of cleavage of both alleles. These results demonstrate the ability to manipulate chromosome content and reveal significant challenges for mutation correction in human embryos.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and that microhomology-mediated end-joining (MMEJ) is the dominant repair pathway in this context (37).”
From Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos (2021) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This suggests that MMEJ-derived large deletions (14, 37) are more likely than microhomology-mediated gene conversion in this context, though protein expression has yet to be fully characterised.”
From Frequent loss of heterozygosity in CRISPR-Cas9–edited early human embryos (2021) · cites this paper as [37]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Search-and-replace genome editing without double-strand breaks or donor DNA
Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., Chen, P. J., Wilson, C., Newby, G. A., Raguram, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1711-4 · Cited by 4,767
To err (meiotically) is human: the genesis of human aneuploidy
Hassold, T. J., & Hunt, P. A. (2001) · Nature Reviews Genetics · doi:10.1038/35066065 · Cited by 2,456
Kosicki, M., Tomberg, K., & Bradley, A. (2018) · Nature Biotechnology · doi:10.1038/nbt.4192 · Cited by 1,883
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
Liang, P., Xu, Y., Zhang, X., Ding, C., Huang, R., Zhang, Z., Lv, J., Xie, X., Chen, Y., Li, Y., et al. (2015) · Protein & Cell · doi:10.1007/s13238-015-0153-5 · Cited by 1,135
Correction of a pathogenic gene mutation in human embryos
Ma, H., Marti-Gutierrez, N., Park, S.-W., Wu, J., Lee, Y., Suzuki, K., Koski, A., Ji, D., Hayama, T., Ahmed, R., et al. (2017) · Nature · doi:10.1038/nature23305 · Cited by 992
Repair of Strand Breaks by Homologous RecombinationPreprint
Jasin, M., & Rothstein, R. J. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012740 · Cited by 929
Self-citationChromosome instability is common in human cleavage-stage embryos
Vanneste, E., Voet, T., Le Caignec, C., Ampe, M., Konings, P., Melotte, C., Debrock, S., Amyere, M., Vikkula, M., Schuit, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.1924 · Cited by 880
Hastings, P. J., Ira, G., & Lupski, J. R. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000327 · Cited by 818
Microhomology-Mediated End Joining: A Back-up Survival Mechanism or Dedicated Pathway?
Sfeir, A., & Symington, L. S. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.08.006 · Cited by 636
Lin, Y., Cradick, T. J., Brown, M. T., Deshmukh, H., Ranjan, P., Sarode, N., Wile, B. M., Vertino, P. M., Stewart, F. J., & Bao, G. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku402 · Cited by 634
Flagged first, then by citations
1 of the 46 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 305
Racing CARs to veterinary immuno-oncology
Cockey, J. R., & Leifer, C. A. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1130182 · Cited by 4
Commercialization of CRISPR-Cas technology: issues and impact
Kharkwal, G. B., Kundu, M. G., Verma, D., & Mishra, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91808-4.00002-x · Cited by 4
Bekaert, B., Boel, A., Rybouchkin, A., Cosemans, G., Declercq, S., Lopes, S. M. C. D. S., Parrington, J., Stoop, D., Coucke, P. J., Menten, B., et al. (2024) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03095-9 · Cited by 4
Perspectives on CRISPR Genome Editing to Prevent Prion Diseases in High-Risk Individuals
Medd, M. M., & Cao, Q. (2024) · Biomedicines · doi:10.3390/biomedicines12081725 · Cited by 4
Emerging Techniques for the Study of Microglia: Visualization, Depletion and Fate MappingPreprint
Bobotis, B. C., Halvorson, T., Carrier, M., & Tremblay, M. (2023) · Preprints.org · doi:10.20944/preprints202308.2190.v1 · Cited by 3
Attenuation of mosaic aneuploidy and erroneous first mitotic division of human embryosPreprint
Currie, C. E., Byrska, A., Taylor, D. M., Erent, M., Bakalova, D. N., Sun, X., Koki, C., Burroughs, N. J., Anderson, R. A., Marston, A. L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.05.647367 · Cited by 4
Interallelic gene conversion of leukemia-associated single nucleotide variants
Silver, A. J., Brown, D. J., Olmstead, S. D., Watke, J., Gorska, A. E., Tanner, L., Ramsey, H. E., & Savona, M. R. (2025) · Gene · doi:10.1016/j.gene.2025.149493 · Cited by 3
Wei, Y., Zhang, M., Hu, J. T., Zhou, Y., Xue, M., Yin, J., Liu, Y., Feng, H., Zhou, L., Li, Z., et al. (2022) · Protein & Cell · doi:10.1093/procel/pwac043 · Cited by 3
Evaluation of guide-free Cas9-induced genomic damage and transcriptome changes in pig embryos
Ge, W., Zhao, X., Gou, S., Jin, Q., Chen, F., Ouyang, Z., Lai, C., Cui, T., Mai, B., Lü, S., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102035 · Cited by 3
Outlook on the Security and Potential Improvements of CRISPR–Cas9
Zha, M.-J., Cai, C., & He, P. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00708-z · Cited by 3
Employing the CRISPR-Cas System for Clonal Hematopoiesis Research.
Ogawa, H., Sano, S., & Walsh, K. X. (2021) · PubMed · doi:10.35248/2329-9096.21.9.582 · Cited by 3
Dowling, J. J. (2022) · Gene Therapy · doi:10.1038/s41434-022-00323-8 · Cited by 3
Huo, X., Sun, X., Xing, X., Lu, J., Zhang, J., Jiang, Y.-B., Zhu, X., Li, C., Lv, J., Guo, M., et al. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf071 · Cited by 6
Optical control of Cas9 activity through visible-light cleavable crRNAs
Hanff, V., Jerabek, S., Langer, K. A., Klimek, R., Kaufmann, J., Kim, J., Egli, D. M., & Heckel, A. (2026) · RSC Chemical Biology · doi:10.1039/d5cb00294j · Cited by 3
Self-citationTarget residence of Cas9: challenges and opportunities in genome editing
Feng, Y.-L., Wang, M., & Xie, A. (2022) · Genome Instability & Disease · doi:10.1007/s42764-022-00066-1 · Cited by 2
A Primer on Gene Editing: What Does It Mean for Pathologists?
Cushman‐Vokoun, A. M., Schmidt, R. J., Hiemenz, M., Fung, M. K. Y., Zhang, B. M., Bradshaw, G., Gandhi, M. J., Yao, J., Yohe, S. L., Beckman, A. K., et al. (2023) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2022-0410-cp · Cited by 2
Redhead, C., Taye, N., & Hubmacher, D. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.08.005 · Cited by 2
Geng, K., Merino, L. G., Veiga, R. G., Sommerauer, C., Epperlein, J., Brinkman, E. K., & Kutter, C. (2023) · Life Science Alliance · doi:10.26508/lsa.202302128 · Cited by 2
Schmidt, J. K., Kim, Y. H., Strelchenko, N. S., Gierczic, S. R., Pavelec, D. M., Golos, T. G., & Slukvin, I. I. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.1031275 · Cited by 2
Genome-Editing – Gentherapie 2.0 oder nur eine Wunschvorstellung?
Fehse, B., Grünewald, J., & Petri, K. (2023) · Springer eBooks · doi:10.1007/978-3-662-67908-1_7 · Cited by 2
Tsang, H., Lillico, S. G., Proudfoot, C., McCulloch, M. E. B., Markby, G. R., Trejo-Reveles, V., CORCORAN, B. M., Whitelaw, B., MacRae, V. E., & SUMMERS, K. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.20.213108 · Cited by 2
Therapeutic immune cell engineering with an mRNA : AAV- Sleeping Beauty composite systemPreprint
Ye, L., Lam, S. Z., Yang, L., Suzuki, K., Zou, Y., Lin, Q., Zhang, Y., Clark, P. R., Peng, L., & Chen, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.14.532651 · Cited by 2
Samach, A., Mafessoni, F., Gross, O., Melamed‐Bessudo, C., Hayut, S. F., Dahan‐Meir, T., Amsellem, Z., Pawlowski, W. P., & Levy, A. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.22.541757 · Cited by 2
Chromosome-level genome editing uncovers aneuploidy addiction in cancer
O’Brien, S., & Berger, A. H. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100618 · Cited by 1
Amirov-Belova, D. (2023) · Legal Science in China and Russia · doi:10.17803/2587-9723.2022.5.093-103 · Cited by 1
Xiao, Z., Wu, Y., Zhang, X., Li, Z., Qiuyu, Z., Caijiao, H., Li, C., Shi, H., Deng, L., Chen, Z., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29061 · Cited by 1
Application of Repetitive Sequences in Fish Cell Depletion as a Target for the CRISPR/Cas9 System
Zhang, Y., Xia, H., Peng, W., Liu, L., Liu, L., & Yang, P. (2024) · Marine Biotechnology · doi:10.1007/s10126-024-10328-6 · Cited by 1
‘Emerging cell-specific therapies in cardiovascular disease’
Mondal, A. R., & Misra, A. (2025) · Vascular Pharmacology · doi:10.1016/j.vph.2025.107516 · Cited by 1
Zhang, Y. (2025) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20250745 · Cited by 1
Yin, J., Wen, H., Zeng, J., Sun, Y., Chen, X., Jin, L. G., Song, Y., & Xia, S. (2026) · Biology of Reproduction · doi:10.1093/biolre/ioag056 · Cited by 1
In vivo adenine base editing of mutant Galc gene ameliorates Krabbe disease progression
Nam, B.-G., Seo, J., Hong, S.-A., Kim, J., Kang, M., Notario, G. R., Hong, Y., Cho, S., Bae, S., & Cho, S.-R. (2026) · Genome Medicine · doi:10.1186/s13073-026-01620-2 · Cited by 1
Human embryo editing: 10 years of breakthroughs and challenges
Zhou, Y., Xie, D., Ding, C., Wu, W., Cao, T., Liu, Q., Keefe, D. L., 周灿权, & Huang, J. (2026) · Protein & Cell · doi:10.1093/procel/pwag030 · Cited by 1
Turocy, J. M., Jerabek, S., Hur, W., Kim, J., Xu, S., Zhao, Q., Xu, J. L., Robles, A., Liu, X., Treff, N. R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73891-7 · Cited by 2
Self-citationOvarian ageing: from biological constraint to emerging therapeutic frontier
Mondal, R., & Nandi, M. (2026) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-026-04011-z · Cited by 1
Highly efficient base editing at PCSK9 and normal human embryo development
Jerabek, S., Jung, C., Kappy, M. D., Zhao, Q., Sung, J., Wang, N., Kim, E., Kim, J., Kulmann, M. I. R., King, M. B., et al. (2026) · Nature · doi:10.1038/s41586-026-11118-x · Cited by 1
Self-citationIjuin, A., Hayama, T., & Sakakibara, H. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15246 · Cited by 1
Rebar, R. W., & Keator, C. S. (2023) · F&S Science · doi:10.1016/j.xfss.2023.03.001 · Cited by 1
Current trends and risks associated with the use of therapies based on genome editing
Анатольевна, Р. О., Melnikova, E. V., & Меркулов, В. А. (2023) · Biological Products Prevention Diagnosis Treatment · doi:10.30895/2221-996x-2023-23-3-247-261 · Cited by 2
Genome instability in mammalian embryos implications for genome editing, development, and evolution
Liu, X., Xu, S., & Egli, D. M. (2025) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2025.102395 · Cited by 1
Self-citationRecent Progress in Genome Editing for Gene Therapy Applications: The French Perspective
Amendola, M., Bedel, A., Buj‐Bello, A., Carrara, M., Concordet, J., Frati, G., Gilot, D., Giovannangeli, C., Gutiérrez-Guerrero, A., Laurent, M., et al. (2021) · Human Gene Therapy · doi:10.1089/hum.2021.191 · Cited by 2
Du, X., Huo, X., Sun, X., Xing, X., Lü, J., Zhang, J., Jiang, Y., Zhu, X., Li, C., Lv, J., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3139100/v1 · Cited by 1
Quantitative analysis of the frequency of chromosome loss following DSB inductionPreprint
Matsuno, S., Ishida, R., Kawasumi, R., Hirota, K., & Abe, T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.15.633104 · Cited by 1
Highway to HHGE: An Interview with Dame Kay E. Davies
Davies, K., & Davies, K. E. (2020) · The CRISPR Journal · doi:10.1089/crispr.2020.29104.kda
Wang, S., Yu, Y., Pan, Y., Wang, H., Zhao, Y., Qu, M., & Zhu, Y. (2021) · BioTechniques · doi:10.2144/btn-2020-0130
Milestones of CRISPR/Cas9 system, promises and roadblocks
Karabiyik, G. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100304
Issues in the Clinical Use of Genome Editing in Human Embryos From a Medical Perspective
Akutsu, H. (2020) · TRENDS IN THE SCIENCES · doi:10.5363/tits.25.10_19
Rana, B., Zimmerman, R., Marín, D., Xu, J. L., Messick, E., Fishel, S. B., & Treff, N. R. (2021) · F&S Science · doi:10.1016/j.xfss.2021.06.001
Self-citationSproul, A. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817876-8.00002-4
Investigating Disease Presentation and Mechanism in RP1L1-Associated Photoreceptor Degeneration
Noel, N. C. L. (2021) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-6bg3-1e79
Chapter 1: The Emergence of Self-Spreading Biotechnology
Beck, F. (2022) · Nomos Verlagsgesellschaft mbH & Co. KG eBooks · doi:10.5771/9783748913528-47
Ryu, J., Burch, F. C., Mishler, E., Neuringer, M. D., Hennebold, J. D., & Hanna, C. B. (2022) · Journal of Animal Reproduciton and Biotechnology · doi:10.12750/jarb.37.4.292
Future Technological Advancements
Doxzen, K. W. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780197616192.003.0011
Using CRISPR-Cas9 In Human Fetuses to Prevent Trisomy 16 and Trisomy 22 Induced Miscarriages
Qin, E., & Guilz, N. C. (2022) · Journal of Student Research · doi:10.47611/jsrhs.v11i4.3859
Application of new technologies in embryos: From gene editing to synthetic embryos
Martin‐Inaraja, M., Romayor, I., Herrera, L., Montserrat, N., & Eguizábal, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91380-5.00032-0
CRISPR technology and its potential role in treating rare imprinting diseases
Nickl, P., Syding, L. A., & Sedláček, R. (2023) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-323-88534-8.00044-4
The Applications of CRISPR/Cas9 System for Urinary System Tumor
Li, S., Wu, Y., & Wang, X. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230504100706
Cao, X., Liu, J., Ling, M., Chen, H., Mao, Y., Cui, A., & Jiang, H. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.2.19
CRISPR/Cas-mediated genome editing and its application on pig-to-human xenotransplantation
Zeng, Y. (2023) · International Conference on Modern Medicine and Global Health (ICMMGH) · doi:10.1117/12.3000215
Cis-regulatory modes of Ultrabithorax inactivation in butterfly forewingsPreprint
Tendolkar, A., Mazo‐Vargas, A., Livraghi, L., Hanly, J. J., Horne, K. C. V., Gilbert, L. E., & Martin, A. (2023) · eLife · doi:10.7554/elife.90846.1
Cha, J. H., Lee, S., Yun, Y., Choi, W. H., Koo, H., Jung, S. H., Chae, H. B., Lee, D. H., Lee, S. J., Jo, D. H., et al. (2023) · medRxiv · doi:10.1101/2023.11.02.23297943
Understanding genetic heterogeneity in gene-edited hematopoietic stem cell products
Becker, H., & Yamazaki, S. (2023) · Experimental Hematology · doi:10.1016/j.exphem.2023.11.007 · Cited by 1
eLife Assessment: Cis-regulatory modes of Ultrabithorax inactivation in butterfly forewings
Chipman, A. D. (2024) · eLife · doi:10.7554/elife.90846.2.sa1
Author Response: Cis-regulatory modes of Ultrabithorax inactivation in butterfly forewings
Tendolkar, A., Mazo‐Vargas, A., Livraghi, L., Hanly, J. J., Horne, K. C. V., Gilbert, L. E., & Martin, A. (2024) · eLife · doi:10.7554/elife.90846.2.sa2
iPSC Models of Ring Chromosomes, Genome Editing, and Chromosome Therapy
Tv, N., & Лебедев, И. Н. (2024) · Springer eBooks · doi:10.1007/978-3-031-47530-6_34
Liu, S., Feng, Y.-L., Sun, X., Chen, R.-D., Liu, Q., Xiao, J., Zhang, J., Huang, Z., Xiang, J.-F., Chen, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20418213
Liu, S., Feng, Y.-L., Sun, X., Chen, R.-D., Liu, Q., Xiao, J., Zhang, J., Huang, Z., Xiang, J.-F., Chen, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20418216
Repair of leukemia-associated single nucleotide variants via interallelic gene conversionPreprint
Silver, A. J., Brown, D. J., Olmstead, S. D., Watke, J., Gorska, A. E., Tanner, L., Ramsey, H. E., & Savona, M. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.16.587991
CRISPR/Cas9-based genetic engineering for translational research in neurological disorders
Megagiannis, P., Rouleau, G. A., & Zhou, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00021-2
PROTAC molecule-mediated SpCas9 protein degradation for precise genome editingPreprint
Sun, S., Sun, R., Tan, M., Kip, M., Yang, X., & Pang, B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.07.631496
CRISPR: fundamental principles and implications for anaesthesia
Perez, A. R., Mavrothalassitis, O., Chen, J. S., Hellman, J., & Gropper, M. A. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.11.040
PAMless and precise sequence replacement by gdt/Cas3 or gdt/Cas9 ribonucleoproteinPreprint
Li, R., Qi, Z., Wanghuang, Y., Wu, D., Xu, Y., Tang, W., Chen, X., Hu, X., Zou, G., Hua, J., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7640593/v1
Chapter 7: Novel Biological Therapies
Blind, J. E., & McConnell, K. (2025) · The American Pharmacists Association eBooks · doi:10.21019/9781582120904.ch7
Vera, A. O., Avilés-Vázquez, F. J., Ha, T., Choudhary, A., & Raines, R. T. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c19089
Unveiling genomic rearrangements in engineered iPSC lines by optical genome mapping
Finlay, D., Hor, P., Goldenson, B., Li, X., Murad, R., Kaufman, D. S., & Vuori, K. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101644
Vinceti, A., Iannuzzi, R. M., Boyle, I., Trastulla, L., Campbell, C. D., Vázquez, F., Dempster, J. M., & Iorio, F. (2024) · Figshare · doi:10.6084/m9.figshare.26751610
Liu, S.-C., Feng, Y.-L., Sun, X.-N., Chen, R.-D., Liu, Q., Xiao, J.-J., Zhang, J.-N., Huang, Z.-C., Xiang, J.-F., Chen, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20418222
Wen, W., Quan, Z.-J., Li, S.-A., Yang, Z.-X., Fu, Y.-W., Zhang, F., Li, G.-H., Zhao, M., Yin, M.-D., Xu, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15982471
Self-citationYuan, B., Bi, C., Tian, Y., Wang, J., Jin, Y., Alsayegh, K. N., Tehseen, M., Yi, G., Zhou, X., Shao, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26714065
Liu, S.-C., Feng, Y.-L., Sun, X.-N., Chen, R.-D., Liu, Q., Xiao, J.-J., Zhang, J.-N., Huang, Z.-C., Xiang, J.-F., Chen, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20418225
Yuan, B., Bi, C., Tian, Y., Wang, J., Jin, Y., Alsayegh, K. N., Tehseen, M., Yi, G., Zhou, X., Shao, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25720308
Yuan, B., Bi, C., Tian, Y., Wang, J., Jin, Y., Alsayegh, K. N., Tehseen, M., Yi, G., Zhou, X., Shao, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25720174
Liu, S.-C., Feng, Y.-L., Sun, X.-N., Chen, R.-D., Liu, Q., Xiao, J.-J., Zhang, J.-N., Huang, Z.-C., Xiang, J.-F., Chen, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20418210
Zhao, J.-J., Sun, X.-Y., Tian, S.-N., Zhao, Z.-Z., Yin, M.-D., Zhao, M., Zhang, F., Li, S.-A., Yang, Z.-X., Wen, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25239456
Liu, S.-C., Feng, Y.-L., Sun, X.-N., Chen, R.-D., Liu, Q., Xiao, J.-J., Zhang, J.-N., Huang, Z.-C., Xiang, J.-F., Chen, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20418207
Zhao, J.-J., Sun, X.-Y., Tian, S.-N., Zhao, Z.-Z., Yin, M.-D., Zhao, M., Zhang, F., Li, S.-A., Yang, Z.-X., Wen, W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25239409
Mianné, J., Nasri, A., Van, C. N., Bourguignon, C., Fieldès, M., Ahmed, E., Duthoit, C. T., Martin, N., Parrinello, H., Louis, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18070820
Vinceti, A., Iannuzzi, R. M., Boyle, I., Trastulla, L., Campbell, C. D., Vázquez, F., Dempster, J. M., & Iorio, F. (2024) · Figshare · doi:10.6084/m9.figshare.26751613
Liu, S.-C., Feng, Y.-L., Sun, X.-N., Chen, R.-D., Liu, Q., Xiao, J.-J., Zhang, J.-N., Huang, Z.-C., Xiang, J.-F., Chen, G., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20418219
Wen, W., Quan, Z.-J., Li, S.-A., Yang, Z.-X., Fu, Y.-W., Zhang, F., Li, G.-H., Zhao, M., Yin, M.-D., Xu, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15982474
Self-citationCRISPR-Cas9 Technology for Combating Genetic Disorders
Sharma, A. K., & Singh, P. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-4857-5.ch005
Gene-Editing-Based Approaches for Curing Sickle Cell Disease
Park, S. H., Karsenty, C. L., Prasca-Chamorro, D., Moyo, B., Yoo, B., & Bao, G. (2026) · Springer eBooks · doi:10.1007/978-3-032-12532-3_8
Factors that contribute to B cell oncogenesis in people living with HIV
Shmakova, A. (2023) · theses.fr (ABES) · doi:10.70675/1d51b9d6z9a12z41f9z8f98z0c7f955aeb54
A fast-to-faithful transition shapes the DNA repair landscape during embryogenesisPreprint
Wang, S., Pantziris, I., Zhang, M., Liu, Y., & Gagnon, J. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.22.720229
Different Types of Gene Therapy
Kumar, S. (2026) · Springer eBooks · doi:10.1007/978-981-95-7688-3_2
Endogenous cell competition kills pathogenic de novo mutant cells but declines under pH stressPreprint
Akieda, Y., Ukawa, H., Watanabe, N., & Ishitani, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.27.721036
Chovanec, P., He, S., & Yin, Y. (2026) · eLife · doi:10.7554/elife.112073
Nguyen, T. H., Nguyen, H. A., Thi, Y.-V. T., Nguyen, H. T., Cao, A., Do, Q. L., Bui, T. T., Duc, T. C., & Cao, H. (2026) · Biotechnology Journal · doi:10.1002/biot.70274
Introduction to rare genetic diseases in fetal development
Bashir, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27660-6.00007-9
Li, F., Ma, X., Xue, Y., Yang, J., Wang, R., Li, X., Zhang, C., Lu, W., Liu, M., Xu, Y., et al. (2026) · Cancer Science · doi:10.1111/cas.70502
Metadata
- Authors
- Zuccaro, M. V., Xu, J., Mitchell, C., Marin, D., Zimmerman, R., Rana, B., Weinstein, E., King, R. T., Palmerola, K. L., Smith, M. E., Tsang, S. H., Goland, R., Jasin, M., Lobo, R., Treff, N., & Egli, D.
- Affiliations
- Columbia University Irving Medical Center (US)
- Genomic Prediction (United States) (US)
- Columbia University (US)
- Rutgers, The State University of New Jersey (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Egli, Dieter
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 183
- Issue
- 6
- Pages
- 1650-1664.e15
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3095871885
- Cited by
- 303
- References
- 46
- Citations by year
- 2026: 27 · 2025: 30 · 2024: 51 · 2023: 64 · 2022: 63 · 2021: 57 · 2020: 11
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nd)
- PubMed (publishedVersion)
- Funders
- Irving Medical Center, Columbia University
- New York Stem Cell Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- CRISPR/Cas9, human embryo, frameshift mutation, microhomology-mediated end joining, DNA double-strand break repair, zygote, paternal allele, chromosome loss, off-target cleavage, indels, embryo mosaicism, germline editing, inherited blindness
- MeSH terms
- Human Embryonic Stem Cells, Gene Editing, CRISPR-Associated Protein 9, Alleles, Animals, Base Sequence, Blastocyst, Cell Cycle, Cell Line, Chromosome Deletion, Chromosomes, Human, Embryo, Mammalian, Eye Proteins, Fertilization, Genotype, Heterozygote, Humans, Mitosis, Embryo Implantation, Gene Rearrangement, Genome, Human, Open Reading Frames, Polymorphism, Single Nucleotide, Mice, DNA Breaks, Double-Stranded, INDEL Mutation, Genetic Loci, DNA End-Joining Repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review